Susquehanna International Group Ltd. Compugen LTD Transaction History

Susquehanna International Group Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.57 - $1.38 $4,248 - $10,286	-7,454 Reduced 9.31%	72,612 $82,000
Q1 2023 May 16, 2023	BUY	$0.68 - $1.11 $54,444 - $88,873	80,066 New	80,066 $56,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $65,174 - $114,094	-15,935 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $92,423 - $127,798	15,935 New	15,935 $96,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.